195 related articles for article (PubMed ID: 34887420)
1. Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy.
Kamel SM; van Opbergen CJM; Koopman CD; Verkerk AO; Boukens BJD; de Jonge B; Onderwater YL; van Alebeek E; Chocron S; Polidoro Pontalti C; Weuring WJ; Vos MA; de Boer TP; van Veen TAB; Bakkers J
Nat Commun; 2021 Dec; 12(1):7151. PubMed ID: 34887420
[TBL] [Abstract][Full Text] [Related]
2. Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
Te Rijdt WP; Asimaki A; Jongbloed JDH; Hoorntje ET; Lazzarini E; van der Zwaag PA; de Boer RA; van Tintelen JP; Saffitz JE; van den Berg MP; Suurmeijer AJH
Cardiovasc Pathol; 2019; 40():2-6. PubMed ID: 30763825
[TBL] [Abstract][Full Text] [Related]
3. Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes.
Posch MG; Perrot A; Geier C; Boldt LH; Schmidt G; Lehmkuhl HB; Hetzer R; Dietz R; Gutberlet M; Haverkamp W; Ozcelik C
Heart Rhythm; 2009 Apr; 6(4):480-6. PubMed ID: 19324307
[TBL] [Abstract][Full Text] [Related]
4. Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related Cardiomyopathy.
Eijgenraam TR; Boogerd CJ; Stege NM; Oliveira Nunes Teixeira V; Dokter MM; Schmidt LE; Yin X; Theofilatos K; Mayr M; van der Meer P; van Rooij E; van der Velden J; Silljé HHW; de Boer RA
Circ Heart Fail; 2021 Nov; 14(11):e008532. PubMed ID: 34587756
[TBL] [Abstract][Full Text] [Related]
5. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts.
Schwinger RH; Böhm M; Schmidt U; Karczewski P; Bavendiek U; Flesch M; Krause EG; Erdmann E
Circulation; 1995 Dec; 92(11):3220-8. PubMed ID: 7586307
[TBL] [Abstract][Full Text] [Related]
6. High resolution systematic digital histological quantification of cardiac fibrosis and adipose tissue in phospholamban p.Arg14del mutation associated cardiomyopathy.
Gho JM; van Es R; Stathonikos N; Harakalova M; te Rijdt WP; Suurmeijer AJ; van der Heijden JF; de Jonge N; Chamuleau SA; de Weger RA; Asselbergs FW; Vink A
PLoS One; 2014; 9(4):e94820. PubMed ID: 24732829
[TBL] [Abstract][Full Text] [Related]
7. Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy.
Feyen DAM; Perea-Gil I; Maas RGC; Harakalova M; Gavidia AA; Arthur Ataam J; Wu TH; Vink A; Pei J; Vadgama N; Suurmeijer AJ; Te Rijdt WP; Vu M; Amatya PL; Prado M; Zhang Y; Dunkenberger L; Sluijter JPG; Sallam K; Asselbergs FW; Mercola M; Karakikes I
Circulation; 2021 Aug; 144(5):382-392. PubMed ID: 33928785
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Badone B; Ronchi C; Lodola F; Knaust AE; Hansen A; Eschenhagen T; Zaza A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948294
[TBL] [Abstract][Full Text] [Related]
9. Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy.
Te Rijdt WP; van der Klooster ZJ; Hoorntje ET; Jongbloed JDH; van der Zwaag PA; Asselbergs FW; Dooijes D; de Boer RA; van Tintelen JP; van den Berg MP; Vink A; Suurmeijer AJH
Cardiovasc Pathol; 2017; 30():23-26. PubMed ID: 28759816
[TBL] [Abstract][Full Text] [Related]
10. Arrhythmia Mechanism and Dynamics in a Humanized Mouse Model of Inherited Cardiomyopathy Caused by Phospholamban R14del Mutation.
Raad N; Bittihn P; Cacheux M; Jeong D; Ilkan Z; Ceholski D; Kohlbrenner E; Zhang L; Cai CL; Kranias EG; Hajjar RJ; Stillitano F; Akar FG
Circulation; 2021 Aug; 144(6):441-454. PubMed ID: 34024116
[TBL] [Abstract][Full Text] [Related]
11. Early calcium and cardiac contraction defects in a model of phospholamban R9C mutation in zebrafish.
Vicente M; Salgado-Almario J; Valiente-Gabioud AA; Collins MM; Vincent P; Domingo B; Llopis J
J Mol Cell Cardiol; 2022 Dec; 173():127-140. PubMed ID: 36273660
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca
Law ML; Prins KW; Olander ME; Metzger JM
Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1544-H1552. PubMed ID: 30118340
[TBL] [Abstract][Full Text] [Related]
13. Gene-Targeted Mice with the Human Troponin T R141W Mutation Develop Dilated Cardiomyopathy with Calcium Desensitization.
Ramratnam M; Salama G; Sharma RK; Wang DW; Smith SH; Banerjee SK; Huang XN; Gifford LM; Pruce ML; Gabris BE; Saba S; Shroff SG; Ahmad F
PLoS One; 2016; 11(12):e0167681. PubMed ID: 27936050
[TBL] [Abstract][Full Text] [Related]
14. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy.
van der Zwaag PA; van Rijsingen IA; Asimaki A; Jongbloed JD; van Veldhuisen DJ; Wiesfeld AC; Cox MG; van Lochem LT; de Boer RA; Hofstra RM; Christiaans I; van Spaendonck-Zwarts KY; Lekanne dit Deprez RH; Judge DP; Calkins H; Suurmeijer AJ; Hauer RN; Saffitz JE; Wilde AA; van den Berg MP; van Tintelen JP
Eur J Heart Fail; 2012 Nov; 14(11):1199-207. PubMed ID: 22820313
[TBL] [Abstract][Full Text] [Related]
15. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.
Minamisawa S; Hoshijima M; Chu G; Ward CA; Frank K; Gu Y; Martone ME; Wang Y; Ross J; Kranias EG; Giles WR; Chien KR
Cell; 1999 Oct; 99(3):313-22. PubMed ID: 10555147
[TBL] [Abstract][Full Text] [Related]
16. Myofilament Alterations Associated with Human R14del-Phospholamban Cardiomyopathy.
Kumar M; Haghighi K; Koch S; Rubinstein J; Stillitano F; Hajjar RJ; Kranias EG; Sadayappan S
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768995
[TBL] [Abstract][Full Text] [Related]
17. Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium.
Movsesian MA; Karimi M; Green K; Jones LR
Circulation; 1994 Aug; 90(2):653-7. PubMed ID: 8044934
[TBL] [Abstract][Full Text] [Related]
18. Viral expression of a SERCA2a-activating PLB mutant improves calcium cycling and synchronicity in dilated cardiomyopathic hiPSC-CMs.
Stroik DR; Ceholski DK; Bidwell PA; Mleczko J; Thanel PF; Kamdar F; Autry JM; Cornea RL; Thomas DD
J Mol Cell Cardiol; 2020 Jan; 138():59-65. PubMed ID: 31751570
[TBL] [Abstract][Full Text] [Related]
19. Phospholamban p.Arg14del cardiomyopathy is characterized by phospholamban aggregates, aggresomes, and autophagic degradation.
Te Rijdt WP; van Tintelen JP; Vink A; van der Wal AC; de Boer RA; van den Berg MP; Suurmeijer AJ
Histopathology; 2016 Oct; 69(4):542-50. PubMed ID: 26970417
[TBL] [Abstract][Full Text] [Related]
20. The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy.
Eijgenraam TR; Boukens BJ; Boogerd CJ; Schouten EM; van de Kolk CWA; Stege NM; Te Rijdt WP; Hoorntje ET; van der Zwaag PA; van Rooij E; van Tintelen JP; van den Berg MP; van der Meer P; van der Velden J; Silljé HHW; de Boer RA
Sci Rep; 2020 Jun; 10(1):9819. PubMed ID: 32555305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
